Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study
DYNA-LCS P
1 other identifier
interventional
15
1 country
1
Brief Summary
This research will enhance our knowledge and understanding of Cerebrospinal Fluid (CSF) circulation around the Central Nervous System (CNS) (brain and spinal cord). The main objective is to obtain flow velocities using Phase Contrast (PC) MRI over the entire subarachnoid space (SAS). This will enable us to develop and validate a numerical model of the SAS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2024
CompletedFirst Posted
Study publicly available on registry
December 19, 2024
CompletedStudy Start
First participant enrolled
September 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2025
CompletedJanuary 5, 2026
January 1, 2026
3 months
December 16, 2024
January 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the velocity displacement of CSF about 7 planes (intracranial plane, C2-C3, C5-C6, T4-T5, T10-T11, L3-L4, L5-S1)
Displacement velocities of CSF will be obtain by Phase Contrats MRI.
Time PC-MRI will be around 60min
Secondary Outcomes (2)
Using morphological MRI to model a digital twin
Time PC-MRI will be around 60min
To evaluate the velocity displacement of blood about 2 planes (intracranial plane, C2-C3)
Time PC-MRI will be around 60min
Study Arms (1)
Phase Contrast MRI
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years at the time of agreement
- Free subject, without guardianship or curatorship or subordination
- Patients benefiting from a Social Security scheme or benefiting from it through a third party
- Informed consent signed by the patient after clear and complete information about the study
You may not qualify if:
- T MRI contraindications (pacemaker, cochlear implant, metallic splinter, etc)
- History of neurological pathology
- Previous operations involving the central nervous system (spinal surgery, neurological surgery, etc.)
- Current pathology or treatment that may interfere with the CSF or subarachnoid spaces (CSF dysregulation, disc herniation, hydrocephalus, Chiari malformation, etc.)
- Concurrent participation in another clinical research study
- Persons not covered by Social Security or not covered by Social Security through a third party
- Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, adults under legal protection
- Pregnant or breastfeeding women, women of childbearing age who do not have effective contraception (hormonal/mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)
- \- Discovery of a contraindication to 3T MRI (pacemaker, cochlear implant, metallic splinter, etc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
C.H.U. Poitiers
Poitiers, 86000, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2024
First Posted
December 19, 2024
Study Start
September 24, 2025
Primary Completion
December 17, 2025
Study Completion
December 17, 2025
Last Updated
January 5, 2026
Record last verified: 2026-01